Release Date: 10/05/21 08:53 Summary: Appointment of Managing Director/CEO Price Sensitive: Yes Download Document 214KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%